Nifty

:

22190.80

Sensex

:

73095.25

-81.70 (-0.37%)
-304.53 (-0.41%)

Login

Nifty
Sensex

:
:

22190.80
73095.25

-81.70 (-0.37%)
-304.53 (-0.41%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

52/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

44.40

15-Apr-2024

Open
High
Low
Previous Close

44.25
45.15
43.05
46.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2744773
1215.53
56.40
25.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,269.59
29.82
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,239.75
N/A
2.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.47
13.02
6.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.98
3.33
-7.67

PAT CAGR (%)

10 Years
5 Years
3 Years

-
6.04
-26.42

P:E (Median)

8 Years
5 Years
3 Years

31.07
24.17
28.06

P:BV (Average)

8 Years
5 Years
3 Years

4.11
3.39
3.43

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.52
14.41
16.47

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 394.63 344.62 14.51% 381.26 383.34 -0.54% 369.10 274.40 34.51% 336.52 342.44 -1.73%
Expenses 343.52 323.17 6.30% 351.50 356.26 -1.34% 344.30 260.79 32.02% 321.39 323.26 -0.58%
EBITDA 51.12 21.45 138.32% 29.76 27.08 9.90% 24.80 13.61 82.22% 15.13 19.18 -21.12%
EBIDTM 12.95% 6.22% 7.81% 7.07% 6.72% 4.96% 4.50% 5.60%
Other Income 3.66 1.19 207.56% 2.84 0.87 226.44% 2.08 0.71 192.96% 2.99 3.11 -3.86%
Interest 2.04 0.55 270.91% 0.45 0.47 -4.26% 0.28 0.40 -30.00% 0.56 0.80 -30.00%
Depreciation 5.51 4.56 20.83% 4.81 4.46 7.85% 4.89 4.37 11.90% 4.61 4.82 -4.36%
PBT 47.22 17.53 169.37% 27.33 23.02 18.72% 21.71 9.55 127.33% 12.94 16.67 -22.38%
Tax 12.02 4.96 142.34% 7.41 6.50 14.00% 5.86 2.68 118.66% 2.67 2.40 11.25%
PAT 35.20 12.57 180.03% 19.92 16.52 20.58% 15.85 6.88 130.38% 10.28 14.27 -27.96%
PATM 8.92% 3.65% 5.23% 4.31% 4.29% 2.51% 3.05% 4.17%
EPS 0.69 0.25 176.00% 0.39 0.32 21.88% 0.31 0.13 138.46% 0.20 0.28 -28.57%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 444.55 348.47 27.57% 421.77 402.98 4.66% 401.04 302.40 32.62% 363.69 368.28 -1.25%
Expenses 393.99 327.94 20.14% 388.18 374.07 3.77% 374.95 287.86 30.25% 348.13 349.61 -0.42%
EBITDA 50.57 20.52 146.44% 33.59 28.91 16.19% 26.09 14.55 79.31% 15.56 18.67 -16.66%
EBIDTM 11.37% 5.89% 7.96% 7.17% 6.51% 4.81% 4.28% 5.07%
Other Income 4.07 1.22 233.61% 3.24 0.87 272.41% 2.42 0.91 165.93% 3.12 3.18 -1.89%
Interest 2.17 0.55 294.55% 0.46 0.47 -2.13% 0.28 0.40 -30.00% 0.56 0.80 -30.00%
Depreciation 8.45 7.19 17.52% 7.69 7.00 9.86% 7.71 6.76 14.05% 6.98 6.88 1.45%
PBT 44.02 14.00 214.43% 28.68 22.31 28.55% 20.51 8.31 146.81% 11.14 14.17 -21.38%
Tax 12.03 5.01 140.12% 7.43 6.50 14.31% 5.88 2.68 119.40% 2.90 1.85 56.76%
PAT 31.99 8.99 255.84% 21.26 15.81 34.47% 14.63 5.63 159.86% 8.24 12.32 -33.12%
PATM 7.20% 2.58% 5.04% 3.92% 3.65% 1.86% 2.27% 3.35%
EPS 0.63 0.18 250.00% 0.42 0.31 35.48% 0.29 0.11 163.64% 0.16 0.26 -38.46%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,481.51 1,338.88 1,449.27 1,112.42 791.99 717.24 560.83 547.51 452.46 370.26 335.97 Net Sales Growth 10.17% -7.62% 30.28% 40.46% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% Cost Of Goods Sold 935.17 847.50 921.58 691.36 487.87 448.98 335.30 328.24 273.04 223.63 194.39 Gross Profit 546.34 491.39 527.68 421.06 304.13 268.26 225.52 219.27 179.42 146.64 141.58 GP Margin 36.88% 36.70% 36.41% 37.85% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% Total Expenditure 1,360.71 1,261.61 1,320.13 1,000.05 727.52 652.22 500.56 487.02 388.26 323.68 290.16 Power & Fuel Cost - 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 % Of Sales - 1.78% 1.31% 1.17% 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% Employee Cost - 146.19 150.00 123.20 98.07 84.74 68.22 60.79 51.67 43.52 39.16 % Of Sales - 10.92% 10.35% 11.07% 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% Manufacturing Exp. - 91.66 98.96 66.82 48.90 31.27 16.21 15.05 13.33 12.63 12.23 % Of Sales - 6.85% 6.83% 6.01% 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% General & Admin Exp. - 50.41 35.93 29.69 31.93 31.21 24.35 21.53 15.34 13.77 14.60 % Of Sales - 3.77% 2.48% 2.67% 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% Selling & Distn. Exp. - 58.42 44.90 44.09 35.75 31.72 29.13 29.04 19.87 16.06 15.11 % Of Sales - 4.36% 3.10% 3.96% 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% Miscellaneous Exp. - 43.66 49.84 31.89 12.45 11.11 16.26 22.53 7.38 6.66 15.11 % Of Sales - 3.26% 3.44% 2.87% 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% EBITDA 120.81 77.27 129.14 112.37 64.47 65.02 60.27 60.49 64.20 46.58 45.81 EBITDA Margin 8.15% 5.77% 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% Other Income 11.57 5.76 20.03 11.77 9.42 3.67 3.54 3.72 1.17 1.36 0.79 Interest 3.33 1.98 2.43 1.79 1.97 2.07 4.29 7.47 10.41 8.63 9.89 Depreciation 19.82 18.01 21.19 28.11 34.43 38.01 33.40 33.56 34.92 38.59 45.77 PBT 109.20 63.04 125.54 94.25 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 Tax 27.96 16.80 24.48 0.00 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 Tax Rate 25.60% 26.65% 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% PAT 81.25 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 PAT before Minority Interest 81.25 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.48% 3.45% 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% PAT Growth 61.72% -54.25% 7.23% 191.52% 13.00% 9.53% 12.73% 46.83% 2,620.69% - EPS 1.59 0.90 1.98 1.84 0.63 0.56 0.51 0.45 0.31 0.01 -0.12

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,631.05 1,417.53 1,546.83 1,188.06 853.07 768.54 606.51 595.47 485.08 400.64 366.85 Net Sales Growth 14.69% -8.36% 30.20% 39.27% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% Cost Of Goods Sold 1,046.31 900.22 980.35 735.29 524.19 479.12 361.28 358.35 293.33 238.62 209.04 Gross Profit 584.74 517.31 566.47 452.77 328.87 289.42 245.23 237.12 191.76 162.02 157.81 GP Margin 35.85% 36.49% 36.62% 38.11% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% Total Expenditure 1,505.25 1,338.00 1,410.15 1,069.54 784.55 701.02 541.78 534.09 423.52 352.41 317.95 Power & Fuel Cost - 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 % Of Sales - 1.68% 1.22% 1.09% 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% Employee Cost - 154.68 164.25 135.59 109.91 95.36 76.53 69.69 58.29 48.79 45.08 % Of Sales - 10.91% 10.62% 11.41% 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% Manufacturing Exp. - 91.70 98.99 67.21 48.92 31.28 16.21 22.36 13.33 12.68 12.23 % Of Sales - 6.47% 6.40% 5.66% 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% General & Admin Exp. - 55.44 42.38 34.71 36.47 36.14 28.52 18.11 18.14 15.89 16.62 % Of Sales - 3.91% 2.74% 2.92% 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% Selling & Distn. Exp. - 66.17 53.58 49.66 40.11 32.73 30.04 25.79 23.45 21.40 19.55 % Of Sales - 4.67% 3.46% 4.18% 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% Miscellaneous Exp. - 46.01 51.67 34.08 12.39 13.20 18.11 29.95 9.35 7.61 19.55 % Of Sales - 3.25% 3.34% 2.87% 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% EBITDA 125.81 79.53 136.68 118.52 68.52 67.52 64.73 61.38 61.56 48.23 48.90 EBITDA Margin 7.71% 5.61% 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% Other Income 12.85 6.13 20.10 12.07 9.48 3.67 3.72 3.72 1.20 1.37 1.22 Interest 3.47 1.98 2.43 1.79 1.98 2.11 4.36 7.56 10.50 8.66 9.92 Depreciation 30.83 27.93 27.64 30.28 36.91 39.90 34.32 33.90 35.20 38.67 45.84 PBT 104.35 55.76 126.70 98.51 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 Tax 28.24 17.08 25.02 1.42 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 Tax Rate 27.06% 30.63% 19.75% 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% PAT 76.12 38.68 101.68 97.09 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 PAT before Minority Interest 76.12 38.68 101.68 97.09 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 PAT Margin 4.67% 2.73% 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% PAT Growth 78.06% -61.96% 4.73% 189.13% 16.40% -2.50% 25.22% 84.61% 498.13% - EPS 1.49 0.76 1.99 1.90 0.66 0.56 0.58 0.46 0.25 0.04 -0.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 780.11 598.17 444.97 307.25 277.46 250.56 224.34 328.85 313.08 324.26 Share Capital 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 Total Reserves 677.89 476.36 311.26 217.29 187.50 160.60 134.38 119.24 103.47 114.65 Non-Current Liabilities 34.45 32.41 26.89 25.36 21.11 17.87 15.28 55.22 72.69 84.05 Secured Loans 0.93 1.32 0.83 0.92 1.79 2.70 0.94 42.74 62.22 74.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 28.87 26.64 24.01 22.38 17.85 13.45 12.69 10.71 8.71 7.35 Current Liabilities 290.98 402.69 375.63 329.38 320.82 322.21 308.19 150.78 114.44 99.58 Trade Payables 213.10 217.32 192.33 158.38 157.08 164.89 116.20 107.48 78.55 66.75 Other Current Liabilities 39.79 159.63 163.93 157.39 153.61 156.05 190.70 39.14 32.82 30.91 Short Term Borrowings 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 Short Term Provisions 14.91 9.61 4.05 2.25 1.14 1.26 1.29 4.16 0.84 0.73 Total Liabilities 1,105.54 1,033.27 847.49 661.99 619.39 590.64 547.81 534.85 500.21 507.89 Net Block 170.82 156.11 144.02 134.84 152.59 182.10 191.29 216.36 243.93 289.47 Gross Block 512.07 479.46 516.17 641.54 777.14 890.30 922.26 914.18 907.16 902.43 Accumulated Depreciation 341.25 323.35 372.14 506.70 624.55 708.20 730.96 697.82 663.23 612.96 Non Current Assets 374.69 356.50 354.71 313.73 336.06 363.54 369.25 387.98 395.80 415.92 Capital Work in Progress 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 117.84 117.79 118.78 118.78 117.69 117.69 117.69 117.69 117.94 117.94 Long Term Loans & Adv. 68.74 68.17 89.67 59.83 65.49 63.47 59.41 53.92 33.93 8.51 Other Non Current Assets 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 Current Assets 730.85 676.76 492.79 348.26 283.33 227.11 178.56 146.88 104.41 91.97 Current Investments 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 Inventories 211.35 258.25 169.61 132.47 90.84 73.94 62.50 40.82 35.36 32.91 Sundry Debtors 255.47 221.87 155.52 121.41 121.96 110.22 83.10 80.35 48.45 40.09 Cash & Bank 55.90 45.55 66.98 38.03 31.98 5.70 6.75 3.63 8.60 8.07 Other Current Assets 208.13 5.07 9.80 5.90 38.52 37.02 26.22 22.08 12.00 10.90 Short Term Loans & Adv. 203.16 146.02 90.88 50.45 30.80 31.53 21.67 16.27 8.89 7.94 Net Current Assets 439.87 274.07 117.16 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 Total Assets 1,105.54 1,033.26 847.50 661.99 619.39 590.65 547.81 534.86 500.21 507.89

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 752.91 578.56 424.75 284.06 253.09 225.94 196.26 300.28 287.48 297.11 Share Capital 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 Total Reserves 650.68 456.75 291.04 194.10 163.13 135.98 106.30 90.67 77.87 87.50 Non-Current Liabilities 36.88 35.50 30.06 28.42 23.38 20.20 17.80 57.47 74.00 84.65 Secured Loans 0.93 1.32 0.83 0.92 1.83 2.95 1.38 43.41 62.27 74.78 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 29.74 28.24 25.39 23.82 19.01 14.42 13.59 11.34 9.22 7.82 Current Liabilities 321.16 456.46 403.80 351.44 339.17 340.12 324.86 166.56 127.92 108.14 Trade Payables 226.88 258.12 208.85 172.30 168.15 174.88 124.88 115.33 84.96 68.60 Other Current Liabilities 54.86 169.97 174.38 165.06 160.64 163.90 198.65 47.04 39.87 37.58 Short Term Borrowings 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 Short Term Provisions 16.24 12.24 5.25 2.72 1.39 1.33 1.33 4.19 0.86 0.77 Total Liabilities 1,110.49 1,070.06 858.15 663.46 615.18 585.81 538.29 523.68 489.00 489.50 Net Block 266.97 251.80 224.52 216.37 236.21 264.29 271.80 296.72 322.48 368.08 Gross Block 656.24 613.25 628.32 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 Accumulated Depreciation 389.27 361.45 403.79 536.18 651.55 733.31 755.15 721.72 686.87 636.53 Non Current Assets 354.33 335.75 331.36 291.29 315.71 342.37 346.34 366.53 374.42 393.18 Capital Work in Progress 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 1.08 1.08 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 70.07 69.53 103.52 73.55 79.22 77.81 73.69 69.82 51.94 25.10 Other Non Current Assets 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 Current Assets 756.16 734.30 526.79 372.18 299.47 243.44 191.95 157.15 114.58 96.32 Current Investments 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 Inventories 228.89 275.85 175.33 138.48 94.20 76.89 64.66 42.14 37.11 33.30 Sundry Debtors 263.25 250.64 181.98 137.68 133.75 121.85 92.95 87.94 56.14 42.67 Cash & Bank 56.31 45.97 67.89 38.88 32.21 5.95 7.59 4.36 8.85 9.11 Other Current Assets 207.73 5.29 10.01 5.98 39.29 38.54 26.74 22.71 12.48 11.24 Short Term Loans & Adv. 200.58 156.54 91.58 51.16 31.43 32.92 22.03 16.77 9.34 8.23 Net Current Assets 435.00 277.84 122.99 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 Total Assets 1,110.49 1,070.05 858.15 663.47 615.18 585.81 538.29 523.68 489.00 489.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -102.12 -68.87 49.31 10.86 14.58 61.25 49.24 50.01 50.74 33.19 PBT 63.04 125.54 94.25 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 Adjustment 18.01 13.02 29.63 34.23 38.36 37.86 40.92 45.32 47.22 55.66 Changes in Working Capital -166.90 -183.04 -74.56 -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 Cash after chg. in Working capital -85.84 -44.47 49.31 16.38 14.58 61.25 49.24 54.27 50.88 30.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.27 -24.39 0.00 -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 Cash From Investing Activity -36.20 -22.64 -69.09 -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 Net Fixed Assets -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 Net Investments -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 Others -0.68 -48.15 -192.50 -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 Cash from Financing Activity 144.20 66.41 47.46 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 Net Cash Inflow / Outflow 5.88 -25.09 27.68 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 Opening Cash & Equivalents 15.38 40.47 12.79 9.36 5.47 6.16 2.87 8.60 8.07 4.72 Closing Cash & Equivalent 21.26 15.38 40.47 12.79 9.36 5.47 6.16 3.63 8.60 8.07

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -91.17 -60.24 50.83 11.02 17.37 63.41 40.73 50.07 50.70 33.52 PBT 55.76 126.70 98.51 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 Adjustment 27.90 19.46 31.96 36.63 40.32 38.64 41.40 45.69 47.32 55.76 Changes in Working Capital -158.28 -181.47 -78.18 -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 Cash after chg. in Working capital -74.62 -35.31 52.29 16.89 17.71 63.41 40.73 54.34 50.83 30.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.55 -24.93 -1.46 -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 Cash From Investing Activity -46.51 -31.68 -70.35 -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 Net Fixed Assets -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 Net Investments -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 Others -10.99 -57.19 -193.76 -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 Cash from Financing Activity 143.54 66.33 47.27 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 Net Cash Inflow / Outflow 5.86 -25.58 27.75 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 Opening Cash & Equivalents 15.80 41.39 13.64 9.60 5.72 7.00 3.60 8.85 9.11 5.53 Closing Cash & Equivalent 21.67 15.80 41.39 13.64 9.60 5.72 7.00 4.36 8.85 9.11

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 15.26 11.97 8.92 6.83 6.17 5.57 4.99 4.65 4.30 4.55 ROA 4.32% 10.75% 12.49% 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% ROE 6.84% 20.77% 26.61% 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% ROCE 9.15% 23.73% 24.54% 10.82% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% Fixed Asset Turnover 2.70 2.91 1.92 1.12 0.86 0.62 0.60 0.51 0.42 0.38 Receivable days 65.07 47.52 45.43 56.08 59.08 62.91 54.48 50.93 42.76 41.07 Inventory Days 64.01 53.88 49.56 51.46 41.93 44.40 34.44 30.13 32.97 37.31 Payable days 92.69 81.12 92.58 79.07 88.97 104.24 84.35 83.75 77.64 70.84 Cash Conversion Cycle 36.39 20.28 2.41 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 Total Debt/Equity 0.03 0.03 0.04 0.04 0.47 0.53 0.22 0.20 0.26 0.27 Interest Cover 32.83 52.75 53.71 20.05 14.82 7.08 4.10 2.50 1.08 0.38

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 14.73 11.56 8.47 6.32 5.63 5.02 4.36 4.02 3.73 3.95 ROA 3.55% 10.55% 12.76% 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% ROE 5.93% 21.79% 29.20% 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% ROCE 8.40% 24.86% 27.13% 12.05% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% Fixed Asset Turnover 2.23 2.49 1.72 1.04 0.82 0.60 0.58 0.49 0.41 0.37 Receivable days 66.16 51.04 49.10 58.07 60.70 64.63 55.44 53.22 44.17 40.16 Inventory Days 64.98 53.23 48.20 49.78 40.63 42.59 32.73 29.27 31.48 34.55 Payable days 98.32 86.93 94.60 79.06 88.85 103.38 82.97 83.88 76.01 67.69 Cash Conversion Cycle 32.82 17.35 2.71 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 Total Debt/Equity 0.03 0.03 0.04 0.05 0.52 0.06 0.25 0.22 0.28 0.30 Interest Cover 29.15 53.22 56.09 20.71 14.83 7.83 4.13 2.21 1.26 0.72

Top Investors:

pinfold overseas limited

morepen laboratories limited - unclaimed suspense account

damodar prasad agarwal

Annual Reports:

News Update:

Morepen Laboratories - Quarterly Results
31st Jan 2024, 14:22 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback